Strides Arcolab gets US FDA nod for Sumatriptan Succinate , Rocuronium Bromide injections

Strides Arcolab Limited has received the US Food and Drug Administration approval for its Sumatriptan Succinate Injection 6 mg (base)/0.5 mL and Rocuronium Bromide 10mg/ml-5ml and 10 ml multi dose vials, a nondepolarizing neuromuscular blocking agent.

Brain tumor enhances artist's vision

Alison Silva has always viewed the world differently than most. In an art class, as her classmates painted a still life of a nude exactly as the model appeared, Silva painted an image of a sky on the woman's body and turned her nipples into buttons from a shirt.

What is migraine aura status?

Home > Topics > What Is Migraine Aura Status? What is migraine aura status?

Endo Pharmaceuticals to Announce Second Quarter 2010 Financial Results on July 30, 2010

CHADDS FORD, Pa., July 20 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its second quarter 2010 financial results on July 30, 2010 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results. David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of R&D, and ...

Endo Pharmaceuticals Recognizes 10 Years as a Public Company by Ringing the NASDAQ Opening Bell

Endo Pharmaceuticals CEO Dave Holveck, along with company executives, will mark Endo's 10th anniversary as a publicly traded company by ringing the opening bell at the NASDAQ Marketsite on Monday, July 19, in Times Square in New York.

Newton doctor talks on headaches

If you suffer from headaches, you are far from alone. Headache is the most common human complaint ever, said Dr. Sarab Alseoudi, neurologist at Newton Medical Center.